MedTrace Logo

Neovascularization Patterns in Corneal Graft Rejection

NCT01695655 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2017-03-15

No results posted yet for this study

Summary

Corneal transplantation is the most commonly performed human tissue transplant worldwide. Over 40,000 corneal transplants occur in the US each year. .

This study will determine specific corneal neovascularization (CN) patterns in human corneal allograft recipients to determine the characteristics that worsen the prognosis for graft survival. We will test the hypothesis that specific characteristics of CN are prognostic for corneal allograft rejection.

Conditions

  • Corneal Transplant

Sponsors & Collaborators

Principal Investigators

  • Roni Shtein, MD, MS · University Of Michigam Kellogg Eye Center

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01695655 on ClinicalTrials.gov